Why I would buy and hold Appen and these quality ASX shares

Appen Ltd (ASX:APX) shares are one of three that I think would be great buy and hold investment options…

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

Over the weekend I demonstrated how buy and hold investing can generate significant wealth for investors.

With that in mind, here are three shares which I think have the potential to be market beaters over the next decade, making them great buy and hold options today:

Appen Ltd (ASX: APX)

When I'm looking for buy and hold options I will first look for an industry or market that has strong growth potential and then ultimately a company that has a leading position within it. That said, I believe Appen is a prime example of what a great buy and hold option looks like. It is the global leader in the development of high-quality, human annotated datasets for an artificial intelligence market forecast to grow materially over the next decade.

REA Group Limited (ASX: REA)

Another top buy and hold option could be this property listings company. I believe its market-leading position in Australia with the realestate.com.au website and its fast-growing international operations have put REA Group in a position to deliver above-average earnings growth once again over the next decade. Furthermore, I believe the fact that the company has continued to achieve strong earnings growth despite the housing market downturn, demonstrates the quality and resilience of its business model.

ResMed Inc (ASX: RMD)

ResMed is a leading developer of products that treat sleep apnea, chronic obstructive pulmonary disease, and other chronic respiratory diseases. According to the company's research, around 1 billion people are estimated to be impacted by sleep apnea worldwide. The vast majority of these people are undiagnosed and at risk of life-threatening conditions such as chronic daytime fatigue, heart disease, stroke, type 2 diabetes, and depression. I expect more and more people to be diagnosed over the next decade, which is likely to lead to increasing demand for its industry-leading products and services.

Motley Fool contributor James Mickleboro has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of Appen Ltd. The Motley Fool Australia has recommended REA Group Limited and ResMed Inc. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Growth Shares

Man pointing an upward line on a bar graph symbolising a rising share price.
Growth Shares

4 top ASX growth shares to buy and hold

Analysts think these stocks are in the buy zone right now.

Read more »

Young woman using computer laptop smiling in love showing heart symbol and shape with hands. as she switches from a big telco to Aussie Broadband which is capturing more market share
Growth Shares

Here are 4 exciting ASX growth stocks that brokers love in 2024

Brokers think investors should be snapping up these growth stocks.

Read more »

A girl is handed an oversized ice cream cone with lots of different flavours.
Growth Shares

How I'd use ASX growth shares to turn $1,000 into $10,000

Choosing the right growth shares can add plenty of bang to your buck.

Read more »

a man in a business suit points his finger amid a digitised map of the globe suspended in the air in front of him, complete with graphs, digital code and glyphs to indicate digital assets.
Investing Strategies

Future focus: How to diversify your portfolio with ASX AI ETFs

Looking for a simple and effective way to capitalise on the growth of AI technologies across global markets?

Read more »

chart showing an increasing share price
Growth Shares

Buy these excellent ASX growth shares for 15% to 20% returns

Analysts think big returns could be on the cards for owners of these shares.

Read more »

Man drawing an upward line on a bar graph symbolising a rising share price.
Growth Shares

These ASX 200 growth shares could rise 12% to 30%

Analysts think big returns could be on offer from these shares.

Read more »

Man in an office celebrates at he crosses a finish line before his colleagues.
Growth Shares

Hoping to beat the ASX 200? I'd consider buying these 3 ASX shares

Analysts think these shares can outperform the market.

Read more »

a happy investor with a wide smile points to a graph that shows an upward trending share price
Growth Shares

5 top ASX growth shares to buy in April

Analysts think growth investors should be buying these shares.

Read more »